BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 38652236)

  • 1. Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer's and Parkinson's Diseases.
    Ayten Ş; Bilici S
    Curr Nutr Rep; 2024 Jun; 13(2):82-96. PubMed ID: 38652236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer's Disease.
    Zhu G; Zhao J; Zhang H; Wang G; Chen W
    Adv Nutr; 2023 Jul; 14(4):819-839. PubMed ID: 37075947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
    Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
    Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified Mediterranean-style diet enhances brain function via specific gut-microbiome-brain mechanisms.
    Park G; Kadyan S; Hochuli N; Pollak J; Wang B; Salazar G; Chakrabarty P; Efron P; Sheffler J; Nagpal R
    Gut Microbes; 2024; 16(1):2323752. PubMed ID: 38444392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Diet and Dietary Components on the Composition of the Gut Microbiota.
    Beam A; Clinger E; Hao L
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
    Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
    EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease.
    Peddinti V; Avaghade MM; Suthar SU; Rout B; Gomte SS; Agnihotri TG; Jain A
    Clin Nutr ESPEN; 2024 Apr; 60():266-280. PubMed ID: 38479921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases.
    Gates EJ; Bernath AK; Klegeris A
    Rev Neurosci; 2022 Oct; 33(7):767-787. PubMed ID: 35304983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases.
    Tao Y; Leng SX; Zhang H
    Curr Neuropharmacol; 2022 Nov; 20(12):2303-2319. PubMed ID: 36043794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Pattern, Gut Microbiota, and Alzheimer's Disease.
    Zhang M; Zhao D; Zhou G; Li C
    J Agric Food Chem; 2020 Nov; 68(46):12800-12809. PubMed ID: 32090565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis.
    Manfready RA; Goetz CG; Keshavarzian A
    Int Rev Neurobiol; 2022; 167():81-99. PubMed ID: 36427960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota.
    Leblhuber F; Ehrlich D; Steiner K; Geisler S; Fuchs D; Lanser L; Kurz K
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33504065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correction of gut dysbiosis as a promising direction in the prevention of neuroinflammation and cognitive impairment].
    Shikh EV; Nikolaeva NB; Molchanova NB; Elizarova EV
    Vopr Pitan; 2023; 92(6):107-119. PubMed ID: 38198424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review.
    Solch RJ; Aigbogun JO; Voyiadjis AG; Talkington GM; Darensbourg RM; O'Connell S; Pickett KM; Perez SR; Maraganore DM
    J Neurol Sci; 2022 Mar; 434():120166. PubMed ID: 35144237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases.
    Czarnik W; Fularski P; Gajewska A; Jakubowska P; Uszok Z; Młynarska E; Rysz J; Franczyk B
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38276546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.